Open on EUR-Lex ↗
◷
New version applies from 16/09/2015 — introduced by Commission Delegated Regulation (EU) 2015/1515. 100 provisions change. Later versions: 12/01/2016, 03/01/2017, 01/04/2017, 30/06/2017, 01/01/2019, 17/06/2019, 18/12/2019, 01/01/2020, 18/06/2020, 11/02/2021, 13/02/2021, 28/06/2021, 12/08/2022, 24/12/2024, 17/01/2025. Recital 21 changes in this version: compare with the current text.

Recital 21

Recital 21

(21)In determining whether a class of OTC derivative contract is to be subject to clearing requirements, ESMA should aim for a reduction in systemic risk. This includes taking into account in the assessment factors such as the level of contractual and operational standardisation of contracts, the volume and the liquidity of the relevant class of OTC derivative contract as well as the availability of fair, reliable and generally accepted pricing information in the relevant class of OTC derivative contract.

Official text · the act as publishedFrom the act as published (consolidated texts do not carry recitals or the preamble). Open full page ↗
9 queries · page built in 157 msInventory f82bbfa3